Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D

…, HZ Mohamedali, H Gulamhusein, AH Panju… - Osteoporosis …, 2013 - Springer
Androgen deprivation therapy in 80 men was associated with declines in bone mineral density
(BMD), which were greatest in the first year, and in the lumbar spine compared to controls…

Associations between quality of life, fatigue, and cytokine levels in patients aged 50+ with acute myeloid leukemia

AH Panju, A Danesh, MD Minden, DJ Kelvin… - Supportive care in …, 2009 - Springer
Goals of work Quality of life (QOL) is significantly impaired in patients with acute myeloid
leukemia (AML), and fatigue is the most common and disabling symptom; effective treatment …

Management of decreased bone mineral density in men starting androgen‐deprivation therapy for prostate cancer

AH Panju, H Breunis, AM Cheung, M Leach… - BJU …, 2009 - Wiley Online Library
OBJECTIVE To determine whether clinicians discuss bone‐specific side‐effects with patients
on androgen‐deprivation therapy (ADT) for prostate cancer, or prescribe lifestyle and …

[HTML][HTML] Policy alternatives for treatments for rare diseases

AH Panju, CM Bell - CMAJ, 2010 - Can Med Assoc
Diseases have varying levels of prevalence in different regions. Hepatocellular carcinoma,
for instance, is highly prevalent in China (incidence of 95.7/100 000 people) but is relatively …

[HTML][HTML] Relationship between Fatigue and Cytokine Levels in Patients Age 50+ with Acute Myeloid Leukemia (AML).

AH Panju, D Kelvin, MD Minden, SMH Alibhai - Blood, 2006 - Elsevier
Several studies have found fatigue to be the most common, persistent, and disabling symptom
affecting patients with AML. Effective measures to prevent or treat fatigue have yet to be …

Impact of androgen deprivation therapy (ADT) on bone mineral density (BMD) over 3 years in men with nonmetastatic prostate cancer.

SMH Alibhai, HZ Mohamedali, AH Panju… - Journal of Clinical …, 2012 - ascopubs.org
193 Background: Decreased BMD is a common side effect of ADT, leading to increased
fracture risk. Although loss of BMD appears to be greatest within the first 12 months of starting …

[PDF][PDF] Management of decreased bone mineral density (BMD) in men starting androgen deprivation therapy (ADT) for prostate cancer

AH Panju, H Breunis, A Cheung… - Critical Reviews in …, 2008 - academia.edu
Background: Sunitinib has shown clinical activity in mRCC. The manageable safety profile
and the oral route represent major advantages in treating elderly patients (pts) but actual …

[PDF][PDF] SMH Alibhai, HZ Mohamedali, H. Gulamhusein, AH Panju, H. Breunis, N. Timilshina, N. Fleshner

MD Krahn, G Naglie - Osteoporos Int, 2013 - researchgate.net
Androgen deprivation therapy in 80 men was associated with declines in bone mineral density
(BMD), which were greatest in the first year, and in the lumbar spine compared to controls…

Symbolicgpt: A generative transformer model for symbolic regression

M Valipour, B You, M Panju, A Ghodsi - arXiv preprint arXiv:2106.14131, 2021 - arxiv.org
Symbolic regression is the task of identifying a mathematical expression that best fits a
provided dataset of input and output values. Due to the richness of the space of mathematical …

[CITATION][C] Predictors of declining bone mineral density in men aged 50+ with prostate cancer undergoing androgen deprivation therapy

AH Panju, H Breunis, A Cheung… - Critical Reviews in …, 2008 - infona.pl
Predictors of declining bone mineral density in men aged 50+ with prostate cancer undergoing
androgen deprivation therapy × Close The Infona portal uses cookies, ie strings of text saved …